Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease

Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease

Pulmonary hypertension (PH) with developmental lung disease is a life-threatening disease and accounts for 10%–12% of pediatric PH patients. Administration of specific pulmonary vasodilators to pediatric PH patients has brought about improvement of their long-term prognosis. Intravenous epoprostenol...

Full description

Bibliographic Details
Main Authors: Yoshie Fukasawa, Hidenori Yamamoto, Miharu Ito, Akiko Saito, Kiyotaka Go, Yoshihito Morimoto, Kazushi Yasuda, Yoshiaki Sato, Masahiro Hayakawa, Taichi Kato
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pediatrics
Subjects:
pulmonary hypertension
developmental lung disease
epoprostenol
congenital diaphragmatic hernia
alveolar capillary dysplasia with misalignment of pulmonary veins
bronchopulmonary dysplasia
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1116434/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2023.1116434/full

Similar Items